Skip to content

Inhaled hydrogen for myocardial injury after non-cardiac surgery (MINS): a multicentre, randomised, single-blind, control clinical trial

A multicentre, randomised, single-blind, control clinical trial of inhaled hydrogen in the treatment of myocardial injury after non-cardiac surgery (MINS)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064172
Enrollment
Unknown
Registered
2022-09-28
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia for non-cardiac surgery

Interventions

Experimental group:Inhalation of hydrogen gas
Control group:No inhalation of hydrogen

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. Patient aged >= 45 years, regardless of gender; 2. Patients intended to undergo elective or emergency non-cardiac surgery under general anaesthesia; 3. Proposed abdominal, orthopaedic or vascular surgery with an operative time of 1 h-4 h; 4. Satisfy any 1 of the following 5 criteria: (1) History of coronary heart disease, including angina pectoris; (2) History of stroke; (3) Undergoing vascular surgery; (4) History of peripheral arterial disease; (5) Any 2 of the following 8 criteria: 1) Acute surgery; 2) History of smoking; 3) History of hypertension; 4) History of diabetes mellitus; 5) History of transient ischaemic disease; 6) Plasma creatinine > 175 µM; 7) Aged 70 years or older; 8) History of congestive heart failure.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Unable to give informed consent prior to surgery; 3. No preoperative oxygen supplementation and a peripheral oxygen saturation (SpO2) of less than 90%; 4. Drug allergy involving any interventional drug; 5. Surgical treatment within 30 days.

Design outcomes

Primary

MeasureTime frame
Troponin level;Incidence of myocardial injury after non-cardiac surgery;

Secondary

MeasureTime frame
All-cause mortality rate;Non-fatal myocardial infarction;Symptoms of myocardial ischemia;Non-fatal serious adverse events;Surgical site infection;pneumonia;Sepsis;Abnormal liver function;Renal insufficiency;Incidence of postoperative delirium;Postoperative hospital stay;ICU stay time;H-FABP;

Countries

China

Contacts

Public ContactLi Yize

Tianjin Medical University General Hospital

liyizelisa@126.com+86 13512224465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026